Ticker Details
Pacific Biosciences of California, Inc. Pacific Biosciences of California Inc is a biotechnology company. It is engaged in design, development, and manufacture of sequencing system to help scientists resolve genetically complex problems.
IPO Date:	October 27, 2010
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$419.62M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 3.65%
Avg Daily Range (30 D):	$0.05 | 4.01%
Avg Daily Range (90 D):	$0.06 | 3.85%

Institutional Daily Volume
Avg Daily Volume:	2.86M
Avg Daily Volume (30 D):	6.5M
Avg Daily Volume (90 D):	5.97M

Trade Size
Avg Trade Size (Sh.):	208
Avg Trade Size (Sh.) (30 D):	366
Avg Trade Size (Sh.) (90 D):	360

Institutional Trades
Total Institutional Trades:	4,461
Avg Institutional Trade:	$2.15M
Avg Institutional Trade (30 D):	$.59M
Avg Institutional Trade (90 D):	$1.04M
Avg Institutional Trade Volume:	.24M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.21M
Avg Closing Trade (30 D):	$.6M
Avg Closing Trade (90 D):	$.99M
Avg Closing Volume:	354.11K

News

Aug 6, 2026 @ 2:52 PM AI Disruption Reshapes Bioinformatics: Record Inve... Source: Bcc Research

Apr 29, 2026 @ 5:00 PM Global Metagenomics Sequencing Market to Register ... Source: Delveinsight

Apr 24, 2026 @ 8:59 AM Omics-Based Clinical Trials Research Report 2026: ... Source: Researchandmarkets.Com

Apr 7, 2026 @ 5:44 PM Global DNA Read, Write and Edit Market to Surge to... Source: Bcc Research

Oct 31, 2025 @ 7:15 AM Genomics Data Analysis Market Size to Surpass USD ... Source: Nova One Advisor

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.43	$-.14	$-.03
Diluted EPS	$-.43	$-.14	$-.03
Revenue	$159.27M	$39.01M	$37.18M
Gross Profit	$57.95M	$12.64M	$12.84M
Net Income / Loss	$-131.39M	$-44.74M	$-8.28M
Operating Income / Loss	$-133.04M	$-44.61M	$-8.36M
Cost of Revenue	$101.33M	$26.37M	$24.34M
Net Cash Flow	$5.97M	$4.74M	$-7.4M
PE Ratio